2008 annual financial data

Iovance Biotherapeutics 2008 Net margin

Direct answer

Net margin was Not calculable.

Operating income was -57,140 USD and net income was -57,140 USD.
Operating cash flow was -57,303 USD.

Get free Iovance Biotherapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
Not available
Operating income
-57,140 USD
Net income
-57,140 USD
Operating cash flow
-57,303 USD